Observational study suggests hepatic arterial infusion pump chemotherapy may be an alternative to resection for patients with multifocal intrahepatic cholangiocarcinoma.
23 May, 2022 | 00:52h | UTCComparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma – JAMA Surgery (link to abstract – $ for full-text)
Commentaries:
Treating iCCA With Chemo Pump Can Be as Effective as Surgery, JAMA Study Finds – AJMC
Commentaries on Twitter
This study found that resection of multifocal intrahepatic cholangiocarcinoma should be carefully considered. Hepatic artery infusion pump chemotherapy may be an effective treatment option. https://t.co/lp1KwSCJvi
— JAMA Surgery (@JAMASurgery) May 12, 2022
In this cohort study of 319 patients with multifocal intrahepatic cholangiocarcinoma, those treated with HAIP floxuridine chemotherapy had similar overall survival to those who underwent resection. @FlavioRochaMD @michael_lidsky @JAMASurgery @HopSTranCao @sepideh_gholami https://t.co/P7O3B7JLRo
— Syed A. Ahmad (@SyedAAhmad5) May 18, 2022